| Autor: |
Papanicolaou GA; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Avery RK; Johns Hopkins University, Baltimore, Maryland, USA., Cordonnier C; Haematology Department, Henri Mondor Hôpital, Assistance Publique-Hopitaux de Paris, and Université Paris-Est-Créteil, Créteil, France., Duarte RF; Department of Haematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Haider S; Juravinski Hospital and Cancer Center, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada., Maertens J; Haematology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Peggs KS; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Solano C; Hematology Department, Hospital Clínico Universitario, University of Valencia, Valencia, Spain., Young JH; University of Minnesota, Minneapolis, Minnesota, USA., Fournier M; Takeda Development Center Americas, Inc, Lexington, Massachusetts, USA., Murray RA; Takeda Development Center Americas, Inc, Lexington, Massachusetts, USA., Wu J; Takeda Development Center Americas, Inc, Lexington, Massachusetts, USA., Bo T; Takeda Development Center Americas, Inc, Lexington, Massachusetts, USA., Winston DJ; Department of Medicine, University of California, Los Angeles Medical Center, Los Angeles, California, USA. |
| Abstrakt: |
Competing Interests: Potential conflicts of interest. G. A. P. reports research funding (paid to their institution) from Merck and Takeda; consulting fees from Merck, Symbio, and Takeda; honoraria from Merck; serving on a data and safety monitoring board or advisory board for AlloVir, Armata, and Vera; and serving as chair (voluntary) for the Transplant Infectious Disease of the American Society for Transplantation and Cellular Therapy. R. K. A. reports study/grant support (paid to their institution) from AiCuris, Astellas, AstraZeneca, Chimerix, Merck, Moderna, Oxford Immunotec, Qiagen, Regeneron, and Takeda. C. C. reports study/grant support (paid to their institution) from Merck Sharp & Dohme and Takeda; consulting fees from Takeda; and honoraria (personal) from Takeda and Merck Sharp & Dohme. R. F. D. reports consulting fees (advisor honoraria) from Cidara, Gilead Sciences, Jazz Pharmaceuticals, Merck Sharp & Dohme, Omeros Corporation, and Sobi; honoraria (speaker's bureau) from Bristol Myers Squibb, Gilead Sciences, Jazz Pharmaceuticals, Merck Sharp & Dohme, Omeros Corporation, and Takeda; support for attending meetings and/or travel from Bristol Myers Squibb, Gilead Sciences, Jazz Pharmaceuticals, Kite Pharma, Merck Sharp & Dohme, Omeros Corporation, and Pfizer; and receipt of equipment and materials from Roche Diagnostics. S. H. reports honoraria (advisory board) from Takeda. J. M. reports honoraria (speaker) and advisory board participation from Takeda; consulting fees from F2G, Gilead Sciences, Mundipharma, and Pfizer; honoraria from F2G, Gilead Sciences, Mundipharma, and Pfizer; support for attending meetings and/or travel from F2G, Gilead Sciences, and Mundipharma; and serving on a data and safety monitoring board or advisory board for Cidara, F2G, Gilead Sciences, Mundipharma, and Takeda. C. S. reports honoraria (speaker) from GSK, Merck Sharp & Dohme, and Pfizer and support for attending meetings and/or travel to an American Society of Hematology Annual Meeting from Kite Pharma, a Gilead company. J.-A. H. Y. reports trial reimbursement (paid to their institution) from Takeda and serving as editor-in-chief for Clinical Microbiology Reviews and as associate editor (unpaid) for Transplantation and Cellular Therapy. M. F., J. W., R. A. M. and T. B. report employee and stock/stock options from Takeda. D. J. W. reports research grants from Ansun Biopharma, Cidara, Symbio, and Takeda and consulting fees from Shire and ViroPharma. The remaining author reports no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. |
